COMPASS THERAPEUTICS, INC.

compass-therapeutics-inc-logo

Compass Therapeutics, Inc. is a clinical-stage biopharmaceutical company, developing antibody therapeutics to treat both solid tumors and hematologic malignancies. Compass is leveraging its proprietary StitchMabsโ„ข and common light-chain enabled multispecific platforms to empirically identify multispecifics and combinations of antibody therapeutics that can be advanced to the clinic. The company's lead product candidate, CTX-009, is a bispecific antibody, which inhibits both DLL4-mediated Notch... signaling and VEGF-A signaling. CTX-009 has completed a Phase 1 dose escalation study and is in a Phase 1b study in combination with chemotherapy in patients with solid tumors. The companyโ€™s second product candidate, CTX-471, is a novel agonistic antibody of CD137, a co-stimulatory receptor on immune cells. It is currently being evaluated in a Phase 1b study in patients who were previously treated with PD-1/PD-L1 checkpoint inhibitors, and who subsequently relapsed or progressed after a period of stable disease. Compassโ€™ third product candidate, CTX-8371, is a bispecific antibody that blocks both PD-1 and PD-L1 and is in IND-enabling studies. The company was founded in 2014 and is headquartered in Boston, Massachusetts.

#SimilarOrganizations #People #Financial #Website #More

COMPASS THERAPEUTICS, INC.

Social Links:

Industry:
Biopharma Biotechnology Therapeutics

Founded:
2014-01-01

Address:
Boston, Massachusetts, United States

Country:
United States

Website Url:
http://www.compasstherapeutics.com

Total Employee:
51+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
176.51 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Google Tag Manager WordPress Content Delivery Network Google Universal Analytics Font Awesome Global Site Tag


Similar Organizations

sagimet-biosciences-logo

Sagimet Biosciences

Sagimet Biosciences is a biotechnology company that focuses on developing novel therapeutics to treat important diseases.

adamis-pharmaceuticals-logo

Adamis Pharmaceuticals

Adamis Pharmaceuticals is a biopharmaceutical company developing therapeutics for respiratory diseases and cancer.

chiasma-logo

Chiasma

Chiasma is a biopharmaceutical company developing oral drugs for the treatment of orphan diseases.

civitas-therapeutics-logo

Civitas Therapeutics

Civitas Therapeutics is a biopharmaceutical company that focuses on developing pulmonary delivery therapies.

edgewise-therapeutics-logo

Edgewise Therapeutics

Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.

proteostasis-therapeutics-logo

Proteostasis Therapeutics

Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.

Current Employees Featured

thomas-schuetz_image

Thomas Schuetz
Thomas Schuetz CEO & Co-Founder @ Compass Therapeutics, Inc.
CEO & Co-Founder
2014-01-01

ben-auspitz_image

Ben Auspitz
Ben Auspitz Director @ Compass Therapeutics, Inc.
Director
2015-06-01

david-weisburd_image

David Weisburd
David Weisburd Investor @ Compass Therapeutics, Inc.
Investor
2015-06-01

Founder


errik-anderson_image

Errik Anderson

thomas-schuetz_image

Thomas Schuetz

Stock Details


Company's stock symbol is NASDAQ:CMPX

Acquisitions List

Date Company Article Price
2021-05-13 Trigr Therapeutics Trigr Therapeutics acquired by Compass Therapeutics, Inc. N/A

Investors List

montrose-capital-partners_image

Montrose Capital Partners

Montrose Capital Partners investment in Venture Round - Compass Therapeutics, Inc.

alexandria-venture-investments_image

Alexandria Venture Investments

Alexandria Venture Investments investment in Venture Round - Compass Therapeutics, Inc.

biomatics-capital-partners_image

Biomatics Capital Partners

Biomatics Capital Partners investment in Venture Round - Compass Therapeutics, Inc.

f-prime-capital-partners_image

F-Prime Capital

F-Prime Capital investment in Venture Round - Compass Therapeutics, Inc.

borealis-ventures_image

Borealis Ventures

Borealis Ventures investment in Venture Round - Compass Therapeutics, Inc.

thiel-capital_image

Thiel Capital

Thiel Capital investment in Venture Round - Compass Therapeutics, Inc.

orbimed-advisors_image

OrbiMed

OrbiMed investment in Venture Round - Compass Therapeutics, Inc.

cowen-healthcare-investments_image

Cowen Healthcare Investments

Cowen Healthcare Investments investment in Venture Round - Compass Therapeutics, Inc.

f-prime-capital-partners_image

F-Prime Capital

F-Prime Capital investment in Series A - Compass Therapeutics, Inc.

thiel-capital_image

Thiel Capital

Thiel Capital investment in Series A - Compass Therapeutics, Inc.

Official Site Inspections

http://www.compasstherapeutics.com Semrush global rank: 1.92 M Semrush visits lastest month: 11.31 K

  • Host name: 198.168.232.35.bc.googleusercontent.com
  • IP address: 35.232.168.198
  • Location: United States
  • Latitude: 38.6583
  • Longitude: -77.2481
  • Timezone: America/New_York

Loading ...

More informations about "Compass Therapeutics, Inc."

Compass Therapeutics, Inc. - Crunchbase Company โ€ฆ

Organization. Compass Therapeutics, Inc. Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. โ€ฆSee details»

Pipeline - Compass Therapeutics

Nov 8, 2024 CTX-471 is an agonistic antibody directed against the co-stimulatory molecule CD137 (4-1BB). CD137, a member of the TNF receptor superfamily of proteins, provides a โ€ฆSee details»

Compass Therapeutics, Inc. - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Compass Therapeutics, Inc. of Brighton, MA. Get the latest business insights from Dun & Bradstreet.See details»

Compass Therapeutics - LifeScienceHistory.com

Www.compasstherapeutics.com. 80 Guest Street, Suite 601. Boston, MA 02135. Company Info Phone (617) 500-8099 Year Established 2013 Ticker CMPX Exchange NASDAQ. Contacts โ€ฆSee details»

Compass Therapeutics - VentureRadar

"Compass Therapeutics is an antibody discovery and development company focused on comprehensively drugging the tumor-immune synapse with combinations of human โ€ฆSee details»

News Release Details - Compass Therapeutics, Inc.

Apr 25, 2024 CTX-009, the Companyโ€™s bispecific DLL4/VEGF-A antibody, in combination with paclitaxel, has shown promising clinical responses in patients with advanced biliary tract โ€ฆSee details»

Compass Therapeutics - MassBio

Compass Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. โ€ฆSee details»

Compass Therapeutics: Revenue, Worth, Valuation & Competitors โ€ฆ

About Compass Therapeutics. Compass Therapeutics is a Biotech related company founded in 2014 and based in Cambridge with 42 employees an estimated revenue of $6M, and. It has 10 โ€ฆSee details»

About โ€“ Compass Therapeutics

Leadership Team. Our leadership team is recognized for their deep experience in drug discovery and development and their unwavering commitment to entrepreneurship and innovation.See details»

Compass Therapeutics - Montrose Capital Partners

Apr 14, 2025 URL: www.compasstherapeutics.com June 2020 APO Financing: $60,500,000 Trading Venue: NASDAQ CM (CMPX) Compass Therapeutics is a clinical-stage biopharmaceutical company developing proprietary antibody โ€ฆSee details»

Home โ€“ Compass Therapeutics, Inc.

Dec 4, 2024 Compass Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases.See details»

Compass Therapeutics (CMPX) Company Profile & Description

Apr 14, 2025 Ticker Symbol: CMPX: Exchange: NASDAQ: Stock Type: Common Stock: Fiscal Year: January - December: Reporting Currency: USD: CIK Code: 0001738021: CUSIP โ€ฆSee details»

Compass Therapeutics Inc. | LinkedIn

Compass Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases.See details»

Compass Therapeutics, Inc. (Compass Therapeutics, Inc.) - ่ฏ็‰ฉ็ฎก โ€ฆ

The company was founded in 2014 and is headquartered in Boston, Massachusetts. For more information, visit the Compass Therapeutics website at https://www.compasstherapeutics.com. โ€ฆSee details»

Compass Therapeutics Announces $80 Million Private Placement

Nov 2, 2022 The company was founded in 2014 and is headquartered in Boston, Massachusetts. For more information, visit the Compass Therapeutics, Inc. website at โ€ฆSee details»

Compass Therapeutics Announces First Patient Dosed in an

1 day ago [email protected] 617-500-8099. Tags biliary tract cancer tovecimig clinical trial MD Anderson. Recommended Reading. April 02, 2025 16:05 ET | Source: โ€ฆSee details»

CMPX - Compass Therapeutics, Inc. | Company Profile | OTC Markets

Mar 20, 2025 www.compasstherapeutics.com (617) 500-8099. [email protected]. Business Description. Compass Therapeutics, Inc. โ€ฆSee details»

Compass Therapeutics to Participate in Upcoming Investor

Nov 13, 2024 [email protected]. Media Contact Anna Gifford, Senior Manager of Communications [email protected] 617-500-8099. Tags Conference ...See details»

Compass Therapeutics Provides Corporate Update and Announces ...

Jan 9, 2025 The company was founded in 2014 and is headquartered in Boston, Massachusetts. For more information, visit the Compass Therapeutics website at โ€ฆSee details»

Compass Therapeutics Doses First Patient in Investigator โ€ฆ

1 day ago [email protected]. Media Contact Anna Gifford, Chief of Staff [email protected] 617-500-8099. This article was originally published on โ€ฆSee details»

linkstock.net © 2022. All rights reserved